Skip to main content
. 2021 Feb 23;41(7):1357–1367. doi: 10.1007/s00296-021-04810-w

Table 2.

Summary of literature review of ANCA-associated vasculitis with Kaposi sarcoma

Author Age, years/sex Diagnosis AAV Organ involvement ANCA type Immunosuppression Time to onset of KS Areas affected by KS HIV and HHV-8 status Treatment Outcome
Our case 77/M Drug-associated MPA Pulmonary-renal syndrome p-ANCA, MPO Glucocorticoids (IV followed by oral prednisone), IV cyclophosphamide 6 Weeks Skin lesions on upper and lower extremities HIV negative, HHV-8 positive Withdrawal of cyclophosphamide, lower prednisone, imiquimod topical Regression KS, vasculitis in remission
Fatma et al.[20] 72/F MPA Pulmonary-renal syndrome Positive p-ANCA, MPO Glucocorticoids (IV followed by oral prednisone), IV cyclophosphamide 5 Months Skin lesions on trunk, lower extremities, face, neck HIV negative, HHV-8 positive Withdrawal of immunosuppression Regression KS, relapse vasculitis with alveolar hemorrhage
Biricik et al.[27] 71/M MPA Pulmonary-renal syndrome p-ANCA positive; MPO/PR3 not tested Glucocorticoids (IV followed by oral prednisone), IV cyclophosphamide 3 Months Skin lesions on lower extremities HIV status not provided, HHV-8 positive Decrease glucocorticoid dose, cyclophosphamide discontinued, radiation therapy Regression KS, vasculitis status not provided
Erban and Sokas[21] 78/M GPA Pulmonary-renal syndrome, chronic sinusitis, arthralgia Not tested Glucocorticoids (oral methylprednisolone), oral cyclophosphamide 10 Weeks Skin lesions on trunk, upper and lower extremities HIV negative, HHV-8 status not provided Glucocorticoid discontinued, cyclophosphamide continued, proton beam radiation to the feet Regression KS, death from cardiogenic shock during cardiac bypass procedure
Deschenes et al.[22] 54/M GPA Sinusitis, cavitary pulmonary lesions c-ANCA, PR3 Glucocorticoids (IV then oral prednisone), oral cyclophosphamide 8 Weeks Skin lesions on trunk, upper and lower extremities HIV negative, HHV-8 status not provided Glucocorticoids tapered off, cyclophosphamide reduced then discontinued after 20 months Regression KS, vasculitis in remission
Hoff and Rødevand[19] 46/M GPA Cranial neuropathies, sinusitis, arthritis, lung nodules

Negative c-ANCA, p-ANCA

MPO/PR3 not tested

Glucocorticoids, IV cyclophosphamide (stopped due adverse effects), methotrexate  ~ 19 Years Skin lesion on ear HIV and HHV-8 status not provided None Died of bladder cancer, vasculitis improved
Bouattar et al.[23] 50/F GPA Glomerulonephritis, L nasal ulceration c-ANCA positive; MPO and PR3 not tested Glucocorticoids (IV followed by oral prednisone), IV cyclophosphamide 18 Weeks Skin lesions on trunk, upper and lower extremities HIV negative, HHV-8 positive Discontinuation of cyclophosphamide, decrease glucocorticoid dose Regression KS followed by recurrence, worsening renal function requiring dialysis, death from DIC
Saxena et al.[25] 66/F GPA Not provided Not provided Glucocorticoids (IV followed by oral prednisone), IV cyclophosphamide 5 Months Skin lesions on trunk and upper and lower extremities HIV status not provided, HHV-8 positive Cyclophosphamide continued for another month then switched to azathioprine, prednisone gradually tapered, azathioprine stopped for worsening KS, IV doxorubicin Regression KS, vasculitis in remission
Kılıç et al. [26] 70/F GPA Nasal septal perforation, glomerulonephritis, pulmonary nodules c-ANCA positive; MPO/PR3 not tested Glucocorticoids (IV followed by oral prednisone), IV cyclophosphamide 0 (Present at diagnosis but worse at 12 weeks) Skin lesions on left lower extremity HIV negative, HHV-8 negative Glucocorticoids decreased, cyclophosphamide discontinued, radiation therapy, systemic chemotherapy (treatment not specified) Not provided
Endo and Nagata[28] 73/M GPA Not provided Not provided Glucocorticoids (IV followed by oral prednisolone), IV cyclophosphamide 4 cycles) then azathioprine 11 Months Gastrointestinal ulcerations (upper and lower tract) HIV negative, HHV-8 positive Corticosteroids tapered from 11 mg per day to 6 mg per day, azathioprine continued Ulcerations and lesions improved, vasculitis in remission
Berti et al. [24] 67/M EGPA Glomerulonephritis, sinusitis, asthma, nasal polyposis Not provided Glucocorticoids (oral), mycophenolate mofetil Not provided Cutaneous HIV negative, HHV-8 positive Mycophenolate mofetil was discontinued, prednisone continued (5 mg per day) Regression KS, vasculitis in remission

AAV anti-neutrophil cytoplasmic antibody-associated vasculitis, ANCA anti-neutrophil cytoplasmic antibody, EGPA eosinophilic granulomatosis with polyangiitis, F Female, GPA granulomatosis with polyangiitis, HHV-8 human herpesvirus 8, HIV human immunodeficiency virus, IV intravenous, KS Kaposi sarcoma, M male, MPA microscopic polyangiitis, MPO myeloperoxidase, PR3 Proteinase 3